DexCom
DXCM
DXCM
418 hedge funds and large institutions have $13.3B invested in DexCom in 2019 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 151 increasing their positions, 148 reducing their positions, and 90 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
4.65% less ownership
Funds ownership: 394.52% → 389.87% (-4.7%)
8% less funds holding
Funds holding: 456 → 418 (-38)
36% less first-time investments, than exits
New positions opened: 58 | Existing positions closed: 90
Holders
418
Holding in Top 10
8
Calls
$68M
Puts
$63.5M
Top Buyers
1 | +$640M | |
2 | +$183M | |
3 | +$157M | |
4 |
Jennison Associates
New York
|
+$142M |
5 |
Capital World Investors
Los Angeles,
California
|
+$140M |
Top Sellers
1 | -$254M | |
2 | -$144M | |
3 | -$123M | |
4 |
HM
HealthCor Management
New York
|
-$87M |
5 |
William Blair Investment Management
Chicago,
Illinois
|
-$71M |